You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
信邦製藥(002390.SZ):UCP、琪康國際及其各自一致行動人擬合計減持不超4%的股份
格隆匯 04-10 17:00

格隆匯4月10日丨信邦製藥(002390.SZ)公佈,持公司股份8523.0788萬股(佔公司總股本比例5.1121%)的公司股東UCPHARM COMPANY LIMITED(“UCP”)及持公司股份1595.09萬股(佔公司總股本比例0.9567%)的股東杭州海東清科技有限公司(“杭州海東清”),計劃在自公告披露之日起15個交易日後的6個月內以集中競價方式減持公司股份合計不超過3334.4572萬股,佔公司總股本比例不超過2.0000%。

持公司股份5468.8935萬股(佔公司總股本比例3.2802%)的股東琪康國際有限公司(“琪康國際”)及持公司股份853.6848萬股(佔公司總股本比例0.5120%)的股東HEALTHY ANGEL INTERNATIONAL LIMITED(“Healthy Angel”),計劃在自公告披露之日起15個交易日後的6個月內以集中競價方式減持公司股份合計不超過3334.4572萬股,佔公司總股本比例不超過2.0000%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account